Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Urol Clin North Am. 2022 May;49(2):273-282. doi: 10.1016/j.ucl.2022.01.003.ABSTRACTInterstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off th...
Source: The Urologic Clinics of North America - April 16, 2022 Category: Urology & Nephrology Authors: Christopher J Chermansky Marina O Guirguis Source Type: research
